RUN vs TXMD · P/E 6.0, rev $2.04B vs rev $1.8M
Sunrun Inc (RUN) versus TherapeuticsMD Inc (TXMD) — a side-by-side from cached financials, not a winner call.
Sunrun Inc (RUN) is a solar company listed on NASDAQ.
TherapeuticsMD Inc (TXMD) is a drug manufacturers - specialty & generic company listed on US.
Latest reported RUN revenue for 2024-12-31 was $2.04B. Net income was -$4.36B. Revenue was down 9.8% from 2023-12-31 to 2024-12-31. RUN currently screens at market cap $3.05B and trailing P/E 6.0.
Latest reported TXMD revenue for 2024-12-31 was $1.8M. Net income was -$2.2M. Revenue was up 35.3% from 2023-12-31 to 2024-12-31. TXMD currently screens at market cap $13.7M.
RUN currently screens at market cap $3.05B and trailing P/E 6.0. TXMD currently screens at market cap $13.7M.
Not investment advice. Open the RUN and TXMD stock pages for the full models.
Not investment advice.